Showing results (211-220 of 243) with videos related to

Sort By:
Pageof 25
Blood|August 23, 2003
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphomaKerry J Savage, Stefano Monti, Jeffery L Kutok, et al.
Science Advances|February 27, 2021
Tumor-specific cytolytic CD4 T cells mediate immunity against human cancerAmélie Cachot, Mariia Bilous, Yen-Cheng Liu, et al.
Nature Communications|January 15, 2015
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cellsCan Küçük, Bei Jiang, Xiaozhou Hu, et al.
Haematologica|May 4, 2023
B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphomaLorenz Thurner, Natalie Fadle, Evi Regitz, et al.
Nature Communications|May 12, 2025
Transcriptome analysis of archived tumors by Visium, GeoMx DSP, and Chromium reveals patient heterogeneityYixing Dong, Chiara Saglietti, Quentin Bayard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2021
Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)Emmanuel Bachy, Vincent Camus, Catherine Thieblemont, et al.
Blood Advances|January 26, 2021
Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphomaFrançois Lemonnier, Violaine Safar, Asma Beldi-Ferchiou, et al.
Nature Communications|October 22, 2024
Modeling NK-cell lymphoma in mice reveals its cell-of-origin and microenvironmental changes and identifies therapeutic targetsJunji Koya, Tomohiko Tanigawa, Kota Mizuno, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2024
Neutralization activity in chronic HIV infection is characterized by a distinct programming of follicular helper CD4 T cellsEirini Moysi, Ashish A Sharma, Sijy O'Dell, et al.
The Lancet. Haematology|May 25, 2024
Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 studyJehan Dupuis, Emmanuel Bachy, Franck Morschhauser, et al.
Pageof 25